Showing results (451-460 of 753) with videos related to
Sort By:
Pageof 76
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.Nature Reviews. Clinical Oncology|April 21, 2023
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumoursMaximilian J Mair, Rupert Bartsch, Emilie Le Rhun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid CancerVivek Subbiah, Robert J Kreitman, Zev A Wainberg, et al.Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.Neuro-Oncology|November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenibBenjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.Cancer|August 27, 2015
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancerLakshmi Nayak, Lisa M DeAngelis, H Ian Robins, et al.Targeted Oncology|January 25, 2013
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptNicole Shonka, Yuji Piao, Mark Gilbert, et al.Neuro-Oncology Advances|August 19, 2021
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysisJames M Snyder, Raymond Y Huang, Harrison Bai, et al.Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.Pageof 76